Connect With Us:
CME Activities
- Omnia Education Series
- Clinician's Guide to Prevention and Treatment of Osteoporosis
- Women's Health Annual Visit
- Fertility Nurse Education
- The Southwest Fertility ForumTM
- Clinician's Commentary
- HPV Testing and Genotyping
- Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
- Non-Invasive Prenatal Testing:
An Advanced Learning Series - Osteoporosis and Fragility Fractures
- Fetal Chromosomal Abnormalities Screening
- Answers from the Experts
- Minimally Invasive Gynecologic Surgery Education
- The Omnia CME Journal: Global Endometrial Ablation for Menorrhagia - The Office Option
- Resources and References
- The Omnia CME Journal: Infertility Nursing
- ECHOTM
A CME Self-Study Activity - Folate Counseling Initiative
- Featured Programs
- Omnia Education Activities
HPV Testing 2012:
What Do the New Guidelines and Emerging Technologies Mean to Your Patients and How You Practice Medicine?
Approximately 80% of sexually active women will have acquired HPV infection by age 50.1
Join us to discuss important developments to the HPV treatment paradigm.
This live webinar will address the following questions:
- What direction is cervical cancer screening heading?
- What do the 2012 HPV guideline updates say about HPV co-testing?
- How will the new mRNA HPV testing technology change your approach to HPV screening?
Date: June 28, 2012
Choose from two convenient times:
12:30 PM ET/9:30 AM PT
Click here to register
3:30 PM ET/12:30 PM PT
Click here to register
| Activity | Date | Location |
|---|
This activity is supported by independent educational grants from Gen-Probe and Quest Diagnostics.
1. Winer, RL et al. Genital HPV infection: Incidence and risk factors in a cohort of female university students. Am J Epid. 2003:157:218-226.